Addex Therapeutics Ltd (ADXN.SW) SIX
Currency In CHF
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 6.21M |
| Enterprise Value | 4.61M |
| P/E Ratio | -0.48 |
| PEG Ratio | -0.02 |
| Price/Sales Ratio | 44.61 |
| Price/Book Ratio | 2.07 |
| Enterprise/Revenue | 33.69 |
| Enterprise/EBITDA | -0.62 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -108.75 |
| Operating Margin | -41.15 |
AD
Management Effectiveness
| Return On Assets | -1.98 |
| Return On Equity | -1.73 |
Income Statement
| Revenue | 173,000 |
| Revenue/Share | 0 |
| Gross Profit | 164,388 |
| EBITDA | -2.82M |
| Net Income | -6.73M |
| Diluted EPS | -0.06 |
Balance Sheet
| Total Cash | 767,328 |
| Total Cash/Share | 0 |
| Total Debt | 77,495 |
| Total Debt/Equity | 0.04 |
| Current Ratio | 0.76 |
| Book Value Per Share | 0.01 |
Price History
| 52-Week Change | -62.95 |
| 52-Week High | 0.07 |
| 52-Week Low | 0.02 |
| Moving Average 50 Days | 0.03 |
| Moving Average 200 Days | 0.04 |
Statistics
| Average Volume | 893,118 |
| Shares Outstanding | 124.73M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
